Old National Bancorp’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,598
| Closed | -$166K | – | 588 |
|
|
2019
Q1 | $166K | Hold |
10,598
| – | – | 0.01% | 547 |
|
|
2018
Q4 | $163K | Sell |
10,598
-200
| -2% | -$3.08K | 0.01% | 544 |
|
|
2018
Q3 | $233K | Sell |
10,798
-284
| -3% | -$6.13K | 0.01% | 564 |
|
|
2018
Q2 | $270K | Sell |
11,082
-108
| -1% | -$2.63K | 0.01% | 522 |
|
|
2018
Q1 | $192K | Sell |
11,190
-1,334
| -11% | -$22.9K | 0.01% | 592 |
|
|
2017
Q4 | $238K | Sell |
12,524
-146
| -1% | -$2.78K | 0.01% | 563 |
|
|
2017
Q3 | $223K | Buy |
12,670
+2,773
| +28% | +$48.8K | 0.01% | 583 |
|
|
2017
Q2 | $329K | Buy |
+9,897
| New | +$329K | 0.02% | 459 |
|
|
2016
Q4 | – | Sell |
-8,781
| Closed | -$404K | – | 645 |
|
|
2016
Q3 | $404K | Sell |
8,781
-1,671
| -16% | -$76.9K | 0.02% | 410 |
|
|
2016
Q2 | $525K | Sell |
10,452
-2,317
| -18% | -$116K | 0.03% | 324 |
|
|
2016
Q1 | $683K | Buy |
12,769
+2,835
| +29% | +$152K | 0.04% | 287 |
|
|
2015
Q4 | $653K | Buy |
9,934
+552
| +6% | +$36.3K | 0.04% | 280 |
|
|
2015
Q3 | $529K | Sell |
9,382
-3,086
| -25% | -$174K | 0.03% | 319 |
|
|
2015
Q2 | $737K | Buy |
12,468
+32
| +0.3% | +$1.89K | 0.04% | 270 |
|
|
2015
Q1 | $775K | Sell |
12,436
-6
| -0% | -$374 | 0.04% | 268 |
|
|
2014
Q4 | $715K | Buy |
12,442
+602
| +5% | +$34.6K | 0.05% | 246 |
|
|
2014
Q3 | $636K | Buy |
11,840
+6,129
| +107% | +$329K | 0.04% | 264 |
|
|
2014
Q2 | $299K | Buy |
+5,711
| New | +$299K | 0.02% | 427 |
|
|
2013
Q4 | – | Sell |
-8,615
| Closed | -$326K | – | 364 |
|
|
2013
Q3 | $326K | Buy |
8,615
+321
| +4% | +$12.1K | 0.03% | 217 |
|
|
2013
Q2 | $325K | Buy |
+8,294
| New | +$325K | 0.03% | 201 |
|